Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer

被引:4
|
作者
Ran, Fanglan [1 ]
Liu, Qjn [1 ]
机构
[1] Chongqing Univ, Dept Resp & Crit Care Med, Fuling Hosp, 2 Gaosuntang Rd, Chongqing 408000, Peoples R China
关键词
Advanced; Non-small cell lung cancer; Prognostic factors; Median survival time; Retrospective analysis; PERFORMANCE STATUS; EXPRESSION; SURVIVAL;
D O I
10.12669/pjms.38.6.5457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: In this study we retrospectively analyzed the prognostic factors of patients with advanced non-small cell lung cancer (NSCLC). Methods: Clinical data of 112 patients with advanced NSCLC treated in the tumor center of our hospital from January 2016 to December 2017 were analyzed retrospectively, follow up the survival of patients, the effects of gender, age, tumor stage, pathological type, performance status (PS) score, smoking history and treatment on the survival of elderly patients with advanced NSCLC were analyzed. Results: The median survival time was 12.0 months, and the median age was 74 years. The 3-year survival rate after confirmation of advanced lung cancer was 6.25%. Kaplan Meier univariate analysis showed that age, PS score, smoking status and treatment correlated with the prognosis(P<0.05). Cox multivariate analysis showed that age >70 years, PS score>2, smoking and no targeted therapy were independent adverse prognostic factors for elderly patients with advanced NSCLC(P<0.05). Conclusions: Age, PS score, smoking and treatment mode affect the prognosis and survival of elderly patients with advanced NSCLC. Effective treatment should be given according to the principle of evidence-based medicine.
引用
收藏
页码:1674 / 1679
页数:6
相关论文
共 50 条
  • [1] Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Honorio, M.
    Guerra Pereira, N.
    Tereso, A.
    Almeida, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S881 - S881
  • [2] Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
    Li, Jian
    Chen, Ping
    Dai, Chun-Hua
    Li, Xiao-Qin
    Bao, Quan-Lei
    ONCOLOGY, 2009, 76 (05) : 355 - 362
  • [3] Prognostic factors in elderly patients with unresectable non-small cell lung cancer
    Kimura, T
    Kudoh, S
    Hirata, K
    Takifuji, N
    Negoro, S
    Yoshikawa, J
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1379 - 1383
  • [4] Advanced non-small cell lung cancer in elderly patients
    Quoix, Elisabeth
    BREATHE, 2012, 9 (01) : 27 - 34
  • [5] Palliative chemotherapy (QT) and prognostic factors in elderly patients with advanced non-small Cell lung cancer (NSCLC)
    Zotano, AG
    Ariño, LP
    Saera, JM
    Abad, LP
    Lorenzo, JP
    Ortiz, AG
    Beveridge, RD
    Huerta, AS
    Salcedo, JM
    LUNG CANCER, 2005, 49 : S246 - S246
  • [6] EFFECT OF PROGNOSTIC FACTORS ON SURVIVAL IN ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Unal, Dilek
    Oguz, Arzu
    Sezgin Goksu, Sema
    Tasdemir, Arzu
    Kurtul, Neslihan
    Eroglu, Celalettin
    Orhan, Okan
    Kaplan, Bunyamin
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2014, 17 (02): : 113 - 118
  • [7] Survival outcomes and prognostic factors in elderly patients with non-small cell lung cancer
    Park, S.
    Park, J. H.
    Kim, J. S.
    Choi, I. S.
    Kim, K. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S192 - S193
  • [8] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [9] Prognostic Factors Affecting Survival in Advanced Non-Small Cell Lung Cancer Patients
    Songur, Necla
    Kuru, Bekir
    Ok, Ugur
    TURKISH THORACIC JOURNAL, 2005, 6 (02) : 91 - 97
  • [10] Prognostic factors in older patients with advanced non-small cell lung cancer in China
    Su, Qiang
    Sun, Yu-Ping
    Liu, Ye-Hui
    Li, Zhe
    Yang, Hong-Yan
    Sun, Zhi-Gang
    Cao, Bang-Wei
    Jia, Ji-Hui
    TUMORI, 2014, 100 (01) : 69 - 74